2seventy bio Reports Fourth Quarter and Full Year 2024 Financial Results [Yahoo! Finance]
2seventy bio, Inc. (TSVT)
Company Research
Source: Yahoo! Finance
Abecma generated $242 million U.S. sales in 2024 79% reduction in year-over-year net cash spend reflects continued streamlining of cost structure Ended 2024 with approximately $184 million in cash, cash equivalents, and marketable securities CAMBRIDGE, Mass., March 25, 2025 BUSINESS WIRE 2seventy bio, Inc . (Nasdaq: TSVT), today reported financial results and recent highlights for the fourth quarter and full year ended December 31, 2024. "2024 was a pivotal year for 2seventy as we made significant changes to our business to streamline cost structure and focus solely on Abecma ," said Chip Baird, chief executive officer, 2seventy bio. "This week marks four years since Abecma received FDA approval as the first anti-BCMA CAR T cell therapy approve
Read more
Impact Snapshot
Event Time:
TSVT
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
TSVT alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
TSVT alerts
High impacting 2seventy bio, Inc. news events
Weekly update
A roundup of the hottest topics
TSVT
News
- 2seventy bio Reports Fourth Quarter and Full Year 2024 Financial ResultsBusiness Wire
- 2seventy bio, Inc. (NASDAQ: TSVT) had its "sell (e+)" rating re-affirmed by analysts at Weiss Ratings.MarketBeat
- 2SEVENTY INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of 2seventy bio, Inc. - TSVTBusiness Wire
- 2seventy bio, Inc. (NASDAQ: TSVT) had its price target lowered by analysts at Morgan Stanley from $6.00 to $5.00. They now have an "equal weight" rating on the stock.MarketBeat
- 2seventy bio, Inc. (NASDAQ: TSVT) was downgraded by analysts at Leerink Partnrs from a "strong-buy" rating to a "hold" rating.MarketBeat
TSVT
Earnings
- 3/25/25 - Miss
TSVT
Sec Filings
- 3/25/25 - Form 10-K
- 3/25/25 - Form 8-K
- 3/19/25 - Form 4
- TSVT's page on the SEC website